Pure Global AI
PMRA Document

PMRA wholesaler purchase waiver (May 2025)

Waiver on requirements for purchase of medical products from wholesalers
MalawiPharmacy and Medicines Regulatory AuthorityRegistrationExpired
Document status

Expired. This text is retained for historical reference.

Document identity

Waiver on requirements for purchase of medical products from wholesalers is published by Pharmacy and Medicines Regulatory Authority. This document is identified by its title; no separate official document code is recorded.

Instrument
Document
Full name
PMRA wholesaler purchase waiver (May 2025)
Category
Registration
Source links
Source publication
English
Linked source text; confirm the publisher, publication details and any later amendment or consolidated version.
Readable HTML
1 language version
Direct citations can link to a specific article or section by appending its fragment identifier.
Dates
Published
2025-05-08
Effective
—
Readable full text

Open a language version

Each version has stable passage anchors for direct citations and highlighting. The readable text is generated from an authority source and does not replace the legally controlling publication.

About this regulation

Waiver on requirements for purchase of medical products from wholesalers

Complete six-paragraph original PMRA web notice concerning licensed and retained pharmaceutical businesses buying medical products from registered wholesalers. The public post publication/last-modified metadata is 8 May 2025; no separate issue date is printed in the notice body. It describes an earlier directive effective 1 April 2025 requiring PMRA receipts for 2025/2026 retention and copies of 2024/2025 business licences. Owing to delayed electronic receipts, it temporarily allows bank deposit slips, while wholesalers must verify customers against the updated business registers. The waiver expressly lasts two months from the notice and does not waive registration or retention itself. This dated waiver is expired and excluded from default current discovery; later renewal is not established. No exact expiry day is invented, and the earlier directive date is not used as the waiver effective date. The two-month duration is not a product registration or variation approval timeline. The notice does not by itself prove identical requirements for the 2026/2027 cycle.

This document is identified by its title; no separate official document code is recorded. Always confirm the current consolidated text and transition provisions with the official source before filing.